Chronic Liver Disease And Cirrhosis Care
Help Questions
USMLE Step 3 › Chronic Liver Disease And Cirrhosis Care
A 55-year-old man with decompensated cirrhosis presents with progressive abdominal distension and dyspnea when supine. He has a history of heavy alcohol use and prior episodes of ascites. He denies fever or abdominal pain. Exam shows tense ascites and mild confusion without focal deficits. Vitals: BP 108/66 mm Hg. Labs: albumin 2.5 g/dL, INR 1.8, creatinine 1.2 mg/dL. Ultrasound confirms large-volume ascites. A therapeutic paracentesis is planned with removal of 7 L. What is the next best step in management for this patient?
Give IV furosemide bolus during the procedure to prevent hypotension
Restrict all dietary protein for 72 hours to prevent encephalopathy
Start broad-spectrum antibiotics regardless of ascitic PMN count
Administer IV albumin after large-volume paracentesis
Explanation
This question tests the management of chronic liver disease and cirrhosis, focusing on clinical decision-making appropriate for independent practice. Chronic liver disease requires careful monitoring and management of complications such as ascites, hepatic encephalopathy, and variceal bleeding. In this vignette, the patient's tense ascites and planned large-volume paracentesis suggest decompensated cirrhosis, requiring immediate assessment and treatment to prevent complications. The correct choice, administering IV albumin after large-volume paracentesis, reflects the appropriate initial management step, aligning with current guidelines for managing cirrhosis and its complications. A common distractor choice, starting broad-spectrum antibiotics regardless of ascitic PMN count, fails because it suggests a non-standard treatment, highlighting a common misconception about liver disease management. To aid learning, emphasize the importance of lifestyle modifications and regular monitoring of liver function to manage and prevent progression of cirrhosis. Encourage the practice of applying standardized guidelines to diverse clinical scenarios.
A 55-year-old man with cirrhosis is admitted with confusion and ascites. He is afebrile and hemodynamically stable. Paracentesis shows PMN 40 cells/mm³. He has not had recent imaging. Exam shows jaundice and asterixis. Which workup step is most appropriate to evaluate for common precipitants of encephalopathy?
Assess for infection, GI bleeding, constipation, and electrolyte abnormalities
Obtain coronary angiography to rule out myocardial infarction
Start chemotherapy to reduce ammonia-producing gut flora
Order liver biopsy urgently to confirm cirrhosis
Explanation
This question tests the management of chronic liver disease and cirrhosis, focusing on clinical decision-making appropriate for independent practice. Chronic liver disease requires careful monitoring and management of complications such as ascites, hepatic encephalopathy, and variceal bleeding. In this vignette, the patient's confusion and asterixis suggest encephalopathy with potential precipitants, requiring immediate assessment and treatment to prevent complications. The correct choice, assessing for infection, GI bleeding, constipation, and electrolyte abnormalities, reflects the appropriate initial management step, aligning with current guidelines for managing cirrhosis and its complications. A common distractor choice, ordering liver biopsy urgently to confirm cirrhosis, fails because it suggests a non-standard treatment, highlighting a common misconception about liver disease management. To aid learning, emphasize the importance of lifestyle modifications and regular monitoring of liver function to manage and prevent progression of cirrhosis. Encourage the practice of applying standardized guidelines to diverse clinical scenarios.
A 50-year-old man with alcohol-associated cirrhosis is evaluated after an episode of hematemesis treated endoscopically with band ligation of esophageal varices. He is now stable and preparing for discharge. He continues to have ascites controlled with diuretics. Vitals are stable; hemoglobin is stable. What is the next best step in management to reduce recurrent variceal bleeding risk?
Begin daily aspirin and clopidogrel to prevent thrombosis
Schedule elective cholecystectomy to reduce portal pressure
Start a proton pump inhibitor as sole long-term prophylaxis
Start a nonselective beta-blocker and arrange repeat banding sessions
Explanation
This question tests the management of chronic liver disease and cirrhosis, focusing on clinical decision-making appropriate for independent practice. Chronic liver disease requires careful monitoring and management of complications such as ascites, hepatic encephalopathy, and variceal bleeding. In this vignette, the patient's recent variceal bleed treated with banding suggests need for secondary prophylaxis, requiring immediate assessment and treatment to prevent complications. The correct choice, starting a nonselective beta-blocker and arranging repeat banding sessions, reflects the appropriate initial management step, aligning with current guidelines for managing cirrhosis and its complications. A common distractor choice, starting a proton pump inhibitor as sole long-term prophylaxis, fails because it suggests a non-standard treatment, highlighting a common misconception about liver disease management. To aid learning, emphasize the importance of lifestyle modifications and regular monitoring of liver function to manage and prevent progression of cirrhosis. Encourage the practice of applying standardized guidelines to diverse clinical scenarios.
A 55-year-old man with known cirrhosis from chronic hepatitis C presents with new confusion and progressive abdominal distension over 3 days. He completed direct-acting antiviral therapy 2 years ago but has had intermittent follow-up. He denies alcohol use for 10 years. He reports decreased appetite and constipation. No fever, cough, dysuria, or GI bleeding symptoms. Exam shows somnolence but arousable, asterixis, scleral icterus, and shifting dullness. Vitals are stable. Labs: Na 130 mEq/L, creatinine 1.3 mg/dL, AST 52 U/L, ALT 40 U/L, total bilirubin 3.6 mg/dL, albumin 2.8 g/dL, INR 2.1, platelets 70,000/µL. Ultrasound shows a nodular liver and large-volume ascites. Diagnostic paracentesis shows PMN 320 cells/mm³; culture pending. He has no focal neurologic deficits. He is admitted for suspected hepatic encephalopathy and ascites. What is the next best step in management for this patient?
Order CT abdomen with contrast before initiating therapy
Begin propranolol immediately to prevent variceal bleeding
Increase dietary protein restriction to <20 g/day
Start IV ceftriaxone for spontaneous bacterial peritonitis
Explanation
This question tests the management of chronic liver disease and cirrhosis, focusing on clinical decision-making appropriate for independent practice. Chronic liver disease requires careful monitoring and management of complications such as ascites, hepatic encephalopathy, and variceal bleeding. In this vignette, the patient's confusion, asterixis, and paracentesis with PMN 320 cells/mm³ suggest spontaneous bacterial peritonitis precipitating encephalopathy, requiring immediate assessment and treatment to prevent complications. The correct choice, starting IV ceftriaxone for spontaneous bacterial peritonitis, reflects the appropriate initial management step, aligning with current guidelines for managing cirrhosis and its complications. A common distractor choice, beginning propranolol immediately to prevent variceal bleeding, fails because it suggests a non-standard treatment, highlighting a common misconception about liver disease management. To aid learning, emphasize the importance of lifestyle modifications and regular monitoring of liver function to manage and prevent progression of cirrhosis. Encourage the practice of applying standardized guidelines to diverse clinical scenarios.
A 60-year-old woman with cirrhosis has recurrent tense ascites requiring paracentesis every 2 weeks despite sodium restriction and maximal tolerated spironolactone/furosemide. She has no active alcohol use and no infection. Labs: Na 126 mEq/L, creatinine 1.1 mg/dL, bilirubin 2.5 mg/dL, INR 1.7. Ultrasound shows patent portal and hepatic veins. What is the next best step in management for this patient?
Begin long-term opioids to reduce abdominal discomfort
Evaluate for TIPS placement for refractory ascites
Stop all diuretics permanently and liberalize sodium intake
Start daily IV normal saline to correct hyponatremia
Explanation
This question tests the management of chronic liver disease and cirrhosis, focusing on clinical decision-making appropriate for independent practice. Chronic liver disease requires careful monitoring and management of complications such as ascites, hepatic encephalopathy, and variceal bleeding. In this vignette, the patient's recurrent tense ascites despite maximal therapy suggest refractory ascites, requiring immediate assessment and treatment to prevent complications. The correct choice, evaluating for TIPS placement for refractory ascites, reflects the appropriate initial management step, aligning with current guidelines for managing cirrhosis and its complications. A common distractor choice, starting daily IV normal saline to correct hyponatremia, fails because it suggests a non-standard treatment, highlighting a common misconception about liver disease management. To aid learning, emphasize the importance of lifestyle modifications and regular monitoring of liver function to manage and prevent progression of cirrhosis. Encourage the practice of applying standardized guidelines to diverse clinical scenarios.
A 60-year-old woman with cirrhosis due to chronic hepatitis C (treated with sustained virologic response) presents for follow-up. She reports increasing abdominal girth and ankle swelling despite limiting salt “most days.” She denies confusion or GI bleeding. Medications include spironolactone 100 mg daily and furosemide 40 mg daily. Exam shows ascites and 2+ leg edema without asterixis. Labs: Na 129 mEq/L, creatinine 1.0 mg/dL, albumin 2.7 g/dL, INR 1.6, total bilirubin 2.2 mg/dL. Ultrasound 6 months ago shows nodular liver and moderate ascites; no mass. She has not had paracentesis before. What is the next best step in management for this patient?
Perform diagnostic paracentesis to evaluate new/worsening ascites
Stop diuretics and encourage free-water intake
Add amlodipine to improve renal perfusion and natriuresis
Start prednisone for presumed autoimmune flare
Explanation
This question tests the management of chronic liver disease and cirrhosis, focusing on clinical decision-making appropriate for independent practice. Chronic liver disease requires careful monitoring and management of complications such as ascites, hepatic encephalopathy, and variceal bleeding. In this vignette, the patient's increasing abdominal girth and edema despite diuretics suggest worsening ascites, requiring immediate assessment and treatment to prevent complications. The correct choice, performing diagnostic paracentesis to evaluate new/worsening ascites, reflects the appropriate initial management step, aligning with current guidelines for managing cirrhosis and its complications. A common distractor choice, adding amlodipine to improve renal perfusion and natriuresis, fails because it suggests a non-standard treatment, highlighting a common misconception about liver disease management. To aid learning, emphasize the importance of lifestyle modifications and regular monitoring of liver function to manage and prevent progression of cirrhosis. Encourage the practice of applying standardized guidelines to diverse clinical scenarios.
A 60-year-old woman with cirrhosis presents for routine surveillance. She has no new symptoms and remains abstinent from alcohol. Labs: bilirubin 1.9 mg/dL, albumin 3.0 g/dL, INR 1.5. Prior ultrasound 6 months ago shows no focal liver lesion. She asks how to monitor for liver cancer. What is the next best step in management for this patient?
PET scan annually to screen for metastatic disease
No surveillance is needed after hepatitis C cure
Ultrasound of the liver every 6 months with or without AFP
CT abdomen with contrast monthly for early detection
Explanation
This question tests the management of chronic liver disease and cirrhosis, focusing on clinical decision-making appropriate for independent practice. Chronic liver disease requires careful monitoring and management of complications such as ascites, hepatic encephalopathy, and variceal bleeding. In this vignette, the patient's cirrhosis and risk for hepatocellular carcinoma suggest need for surveillance, requiring immediate assessment and treatment to prevent complications. The correct choice, ultrasound of the liver every 6 months with or without AFP, reflects the appropriate initial management step, aligning with current guidelines for managing cirrhosis and its complications. A common distractor choice, no surveillance is needed after hepatitis C cure, fails because it suggests a non-standard treatment, highlighting a common misconception about liver disease management. To aid learning, emphasize the importance of lifestyle modifications and regular monitoring of liver function to manage and prevent progression of cirrhosis. Encourage the practice of applying standardized guidelines to diverse clinical scenarios.
A 60-year-old woman with cirrhosis presents with increasing abdominal distension. Paracentesis reveals a serum-ascites albumin gradient (SAAG) of 1.6 g/dL and ascitic total protein 0.9 g/dL. She has no fever and PMN count is 40 cells/mm³. Ultrasound shows cirrhosis and portal hypertension. Which of the following findings is most consistent with portal hypertensive ascites?
Ascitic PMN >250 cells/mm³ with negative culture
SAAG ≥1.1 g/dL
SAAG <1.1 g/dL
Ascitic amylase markedly elevated above serum
Explanation
This question tests the management of chronic liver disease and cirrhosis, focusing on clinical decision-making appropriate for independent practice. Chronic liver disease requires careful monitoring and management of complications such as ascites, hepatic encephalopathy, and variceal bleeding. In this vignette, the patient's SAAG of 1.6 g/dL and low ascitic protein suggest portal hypertensive ascites, requiring immediate assessment and treatment to prevent complications. The correct choice, SAAG ≥1.1 g/dL, reflects the appropriate initial management step, aligning with current guidelines for managing cirrhosis and its complications. A common distractor choice, SAAG <1.1 g/dL, fails because it suggests a non-standard treatment, highlighting a common misconception about liver disease management. To aid learning, emphasize the importance of lifestyle modifications and regular monitoring of liver function to manage and prevent progression of cirrhosis. Encourage the practice of applying standardized guidelines to diverse clinical scenarios.
A 60-year-old woman with known cirrhosis due to hepatitis C presents with worsening ascites and mild confusion. She has no fever. Paracentesis shows PMN 260 cells/mm³. She is treated for SBP and improves. To reduce recurrence risk, what is the next best step in management after completing antibiotics?
Start long-term SBP prophylaxis with oral antibiotic therapy
No prophylaxis is needed if symptoms resolve
Stop diuretics permanently and rely on serial paracenteses only
Begin chronic prednisone to suppress peritoneal inflammation
Explanation
This question tests the management of chronic liver disease and cirrhosis, focusing on clinical decision-making appropriate for independent practice. Chronic liver disease requires careful monitoring and management of complications such as ascites, hepatic encephalopathy, and variceal bleeding. In this vignette, the patient's history of SBP suggests need for prophylaxis, requiring immediate assessment and treatment to prevent complications. The correct choice, starting long-term SBP prophylaxis with oral antibiotic therapy, reflects the appropriate initial management step, aligning with current guidelines for managing cirrhosis and its complications. A common distractor choice, no prophylaxis is needed if symptoms resolve, fails because it suggests a non-standard treatment, highlighting a common misconception about liver disease management. To aid learning, emphasize the importance of lifestyle modifications and regular monitoring of liver function to manage and prevent progression of cirrhosis. Encourage the practice of applying standardized guidelines to diverse clinical scenarios.